Clinical Trials Directory

Trials / Completed

CompletedNCT00856869

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

A Study in Healthy Volunteers and Patients With Liver Cirrhosis and Non-Alcoholic Steatohepatitis (NASH) to Assess the Effects of Age, Gender, Chronic Liver Disease, and Prandial Effects on the Clearance of Cholyl-Lysyl-Fluorescein (NRL972) an an in-Vivo Marker of Liver Function in Man.

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Norgine · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The study was conducted to describe and compare the plasma pharmacokinetics of NRL972 administered after a standard meal and while fasted in patients with hepatic cirrhosis (Child-Turcotte-Pugh \[CTP\] class A-C), NASH, young and elderly healthy males, and young and elderly healthy females, to assess the effects of liver dysfunction, gender, age and prandial intestinal hyperaemia on the clearance of NRL972. In addition, the study was to provide information on the safety and tolerability of repeated intravenous doses of NRL972 in these populations.

Conditions

Interventions

TypeNameDescription
DRUGNRL972Single 2 mg intravenous injection administered once after an overnight fast and once after a standard meal
DRUGNRL972Single 2 mg intravenous injection administered once after an overnight fast and once after a standard meal
DRUGNRL972Single 2 mg intravenous injection administered once after an overnight fast and once after a standard meal
DRUGNRL972Single 2 mg intravenous injection administered once after an overnight fast and once after a standard meal
DRUGNRL972Single 2 mg intravenous injection administered once after an overnight fast and once after a standard meal
DRUGNRL972Single 2 mg intravenous injection administered once after an overnight fast and once after a standard meal
DRUGNRL972Single 2 mg intravenous injection administered once after an overnight fast and once after a standard meal

Timeline

Start date
2004-08-01
Primary completion
2005-02-01
Completion
2005-04-01
First posted
2009-03-06
Last updated
2009-03-06

Locations

1 site across 1 country: Bulgaria

Source: ClinicalTrials.gov record NCT00856869. Inclusion in this directory is not an endorsement.